SEC Form 4 · accession 0001079974-15-000251

OMNI BIO PHARMACEUTICAL, INC. · OMBP

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

10% Owner

Period of report

Apr 18, 2014

Accepted (ET)

Apr 9, 2015 · 6:02 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001389870

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common	Feb 27, 2015	P	2,998,678	$0.25	A	10,132,678	D
Common	Feb 27, 2015	P	3,000,000	$0.01	A	13,132,678	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Warrant	$0.25	Apr 18, 2014	J	2,900,000	D	Mar 31, 2009	Mar 31, 2017	Common Stock	2,900,000	7,350,000	D
Warrant	$0.25	Apr 18, 2014	J	1,450,000	D	Mar 31, 2009	Mar 31, 2017	Common Stock	1,450,000	7,350,000	D
Warrant	$0.25	Apr 18, 2014	J	2,900,000	A	Mar 31, 2009	Dec 31, 2019	Common Stock	2,900,000	7,350,000	D
Warrant	$0.25	Apr 18, 2014	J	1,450,000	A	Mar 31, 2009	Dec 31, 2019	Common Stock	1,450,000	7,350,000	D
Warrant	$0.01	Apr 18, 2014	P	3,000,000	A	Apr 18, 2014	Apr 15, 2015	Common Stock	3,000,000	10,350,000	D
Convertible Note	$0.25	Feb 27, 2015	C	2,400,000	D	Oct 31, 2012	Oct 31, 2015	Common Stock	2,998,678	7,950,000	D
Warrant	$0.01	Feb 27, 2015	X	3,000,000	D	Apr 18, 2014	Apr 15, 2015	Common Stock	3,000,000	4,950,000	D

F1This Warrant amends and restates in its entirety a previous Warrant for the same number of shares for the purpose extending the contractual period to December 31, 2019 and resetting of the Exercise Price to $0.25.
F2Conversion of the previously reported $600,000 Convertible Promissory Note with principal of $600,000 and accrued interest of $149,669.58.
F3Exercise of the previously reported 3,000,000 warrants.